Nicola Coley

1979 -

country of citizenship: United Kingdom

languages spoken, written or signed: English

educated at: University of Birmingham, London School of Hygiene & Tropical Medicine, Toulouse III University - Paul-Sabatier

occupation: epidemiologist

Series

There is nothing here

Create a new serie

Works

There is nothing here

Create a new work

Articles 34

Date

Title

Authors

2018-01-01

Trajectory of the MAPT-PACC-Preclinical Alzheimer Cognitive Composite in the Placebo Group of a Randomized Control Trial: Results from the MAPT Study: Lessons for Further Trials.

Nicola Coley
2018-01-01

Defining the Optimal Target Population for Trials of Polyunsaturated Fatty Acid Supplementation Using the Erythrocyte Omega-3 Index: A Step Towards Personalized Prevention of Cognitive Decline?

Nicola Coley
2018-10-17

Anticholinergic exposure and cognitive decline in older adults: effect of anticholinergic exposure definitions in a 3-year analysis of the multidomain Alzheimer preventive trial (MAPT) study

Laurine Andre, Nicola Coley, Jean-Louis Montastruc
2017-03-04

Effect of dementia on receipt of influenza vaccine: a cohort study in French older adults using administrative data: 2007-2012.

Adeline Gallini, Nicola Coley, Virginie Gardette
2017-03-06

Determinants of Dropout and Nonadherence in a Dementia Prevention Randomized Controlled Trial: The Prevention of Dementia by Intensive Vascular Care Trial

Cathrien R L Beishuizen, Nicola Coley
2017-09-12

Improving data sharing in research with context-free encoded missing data

Marieke Peternella Hoevenaar-Blom, Tiia Ngandu, Nicola Coley, Carol Brayne, Miia Kivipelto
2017-11-06

Cross-sectional Associations of Fatigue with Cerebral β-Amyloid in Older Adults at Risk of Dementia

Nicola Coley, Pierre Payoux
2017-01-01

Cross-Sectional Associations of Total Plasma Homocysteine with Cortical β-Amyloid Independently and as a Function of Omega 3 Polyunsaturated Fatty Acid Status in Older Adults at Risk of Dementia

Nicola Coley, Pierre Payoux
2017-01-01

Cognitive Changes with Omega-3 Polyunsaturated Fatty Acids in Non-Demented Older Adults with Low Omega-3 Index

Nicola Coley
2017-07-11

Lessons from the Multidomain Alzheimer Preventive Trial - Authors' reply

Nicola Coley
2016-06-10

Healthy Ageing Through Internet Counselling in the Elderly: the HATICE randomised controlled trial for the prevention of cardiovascular disease and cognitive impairment

Hilkka Soininen, Nicola Coley, Miia Kivipelto, Carol Brayne, Tiia Ngandu, Juliette Guillemont
2015-05-14

Nutrition and Cognition in Aging Adults

Nicola Coley
2015-07-23

Prevention of sporadic Alzheimer's disease: lessons learned from clinical trials and future directions

Nicola Coley, Simon Lovestone, Bruno Vellas, Paul S. Aisen
2015-07-19

Prevention studies in Alzheimer's disease: progress towards the development of new therapeutics

Nicola Coley
2015-10-23

Assessing Alzheimer's disease patients' quality of life: Discrepancies between patient and caregiver perspectives

Nicola Coley, Catherine Arnaud
2013-07-01

How to design nutritional intervention trials to slow cognitive decline in apparently healthy populations and apply for efficacy claims: a statement from the International Academy on Nutrition and Aging Task Force

Nicola Coley, Antoni Salvà
2012-09-06

Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial

Nicola Coley, Bruno Dubois, Bruno Vellas, Jean-François Dartigues
2012-07-19

Methodological challenges in designing dementia prevention trials - the European Dementia Prevention Initiative (EDPI).

Nicola Coley, Miia Kivipelto, Bruno Vellas
2012-01-20

Improving care of older adults with dementia: description of 6299 hospitalizations over 11 years in a special acute care unit

Virginie Gardette, Nicola Coley, Bruno Vellas
2012-06-01

Rationale for use of the Clinical Dementia Rating Sum of Boxes as a primary outcome measure for Alzheimer's disease clinical trials.

Nicola Coley, Alzheimer's Disease Neuroimaging Initiative, Bruno Vellas
2011-11-01

Long-term progression of Alzheimer's disease in patients under antidementia drugs

Nicola Coley, Virginie Gardette, Bruno Vellas
2011-03-21

Public financial support receipt and non-medical resource utilization in Alzheimer's disease results from the PLASA study.

Nicola Coley, Bruno Vellas
2011-07-13

Suitability of the Clinical Dementia Rating-Sum of Boxes as a single primary endpoint for Alzheimer's disease trials

Nicola Coley
2010-12-02

Biomarkers for Alzheimer's disease therapeutic trials

Nicola Coley, Nick C. Fox, Giovanni B. Frisoni, Simon Lovestone, Philip Scheltens, Harald Hampel, Kaj Blennow, Agneta Nordberg, Bengt Winblad, Maria C Carrillo, Bruno Vellas, Paul S. Aisen, Michael W. Weiner, David Prvulovic, Sandrine Andrieu
2009-01-01

Methodological issues in primary prevention trials for neurodegenerative dementia

Nicola Coley, Eric Salmon, Giovanni B. Frisoni, Cristina Sampaio, Maria C Carrillo, John C. Morris, Bruno Vellas, Paul S. Aisen, Zaven S Khachaturian, Steven T. DeKosky, Frans RJ Verhey, Roy W Jones
2009-03-30

Determinants of students' attitudes towards peers with disabilities.

Nicola Coley, Emmanuelle Godeau
2009-02-21

Cardiovascular disease risk factors and progression of Alzheimer's disease.

Nicola Coley, Bruno Vellas
2009-10-01

Biomarkers in Alzheimer's disease: not yet surrogate endpoints.

Nicola Coley
2008-01-01

Memory complaints to the general practitioner: data from the GuidAge study

Nicola Coley
2008-02-08

Measuring children's attitudes towards peers with disabilities: a review of instruments

Emmanuelle Godeau, Nicola Coley
2008-05-01

Endpoints for trials in Alzheimer's disease: a European task force consensus

Nicola Coley, Cristina Sampaio, Bruno Vellas
2008-07-12

Predictive factors of attrition in a cohort of Alzheimer disease patients. The REAL.FR study.

Nicola Coley, Virginie Gardette, Bruno Vellas

Human - wd:Q37836484

Welcome to Inventaire

the library of your friends and communities

learn more